Drugs / GSK568893A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00359619 | Sep 2006 → Jan 2007 | human papilloma virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK568893A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00359619 ↗ |
| Modality | Vaccine | “HPV investigational vaccine GSK568893A, different formulations” NCT00359619 ↗ |
| Route | Intramuscular | “The vaccine was administered intramuscularly into the deltoid region of the non-dominant arm.” NCT00359619 ↗ |